GlassScriptPhysician profile
Irina Mikheyeva
NPI 1245411354
$2,614.14
in general payments reported to CMS, 2019-2025
20 companies · $261 in 2025
The $261 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $229 · 2020: $263 · 2021: $436 · 2022: $435 · 2023: $577 · 2024: $413 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,166 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,166.27 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $473.16 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $448.85 | 2023-2025 | Gemtesa, Myfembree |
| Astellas Pharma US INC | $385.50 | 2019-2025 | Veozah, Myrbetriq |
| Pfizer INC. | $367.20 | 2019-2024 | |
| Urovant Sciences INC | $239.50 | 2021-2022 | |
| Coopersurgical, INC. | $126.13 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Mylan Pharmaceuticals INC. | $87.12 | 2019-2021 | |
| Daiichi Sankyo INC. | $69.93 | 2019-2020 | |
| Therapeuticsmd, INC. | $67.39 | 2022 | |
| Shield Therapeutics INC | $64.98 | 2023-2025 | Accrufer |
| Mayne Pharma Commercial LLC | $59.25 | 2024-2025 | |
| Avion Pharmaceuticals | $48.40 | 2019-2021 | |
| Myovant Sciences INC. | $36.44 | 2021 | |
| Csl Behring | $26.40 | 2023 | Kcentra |
| Astrazeneca Pharmaceuticals LP | $23.13 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $23.06 | 2021 | |
| Organon LLC | $18.09 | 2023 | Nexplanon |
| Heartflow, INC. | $17.71 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.60 | 2021 | |
| Amgen INC. | $15.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irina Mikheyeva listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.